Special Report Casey Ross Epic’s overhaul of a flawed algorithm shows why AI oversight is a life-or-death issue
Special Report Casey Ross and Mohana Ravindranath Minimal compliance, or meaningful change? Epic faces a crossroads as new rules put pressure on health data sharing
Special Report Olivia Goldhill Tobacco giant Philip Morris is investing billions in health care. Critics say it’s peddling cures for its own poison
Special Report Usha Lee McFarling ‘So much more to do’: A hospital system’s campaign to confront racism — and resistance to change — makes early strides
Special Report Bob Herman, Kate Sheridan, J. Emory Parker, Adam Feuerstein and Mohana Ravindranath Health care’s high rollers: As the pandemic raged, CEOs’ earnings surged
Special Report Usha Lee McFarling 20 years ago, a landmark report spotlighted systemic racism in medicine. Why has so little changed?
Prescription Politics Lev Facher More than two-thirds of Congress cashed a pharma campaign check in 2020, new STAT analysis shows
Special Report Casey Ross Microsoft’s note-taking tool asks doctors to make a grand bargain: Share patient data, and get your life back
Special Report Tara Bannow and Bob Herman Private equity’s Welsh Carson, casting itself as a noble force, relentlessly pursues profits in health care
Special Report Karen Pennar ‘If I were a hospital, I’d be reading the tea leaves’: Pressures grow on the health care industry to reduce its climate pollution
Special Report Sarah Owermohle A minuscule new HHS office has a mammoth goal: tackling environmental justice
Special Report Andrew Joseph Two deadly days in St. Louis: An overdose cluster kills 8 Black people — and shows the new shape of the addiction crisis
Special Report Eric Boodman In the label ‘adult failure to thrive,’ medicine reveals its own failures
Special Report Angus Chen This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women
Special Report Andrew Joseph To protect people with addiction from discrimination, the Justice Dept. turns to a long-overlooked tool: the ADA
Special Report Todd Feathers, Simon Fondrie-Teitler, Angie Waller, and Surya Mattu — The Markup Facebook is receiving sensitive medical information from hospital websites
Special Report Angus Chen ‘How do you decide?’: Cancer treatment’s CAR-T crisis has patients dying on a waitlist
Special Report Jonathan Moens Costly Alzheimer’s treatment is spreading around the world, with virtually no science to back it up
Special Report Megan Molteni From burst bubble to medical marvel: How lipid nanoparticles became the future of gene therapy
Special Report Matthew Herper How Paxlovid came to be: From the germ of an idea to a vital tool against Covid
Special Report STAT Staff Covid hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel
Special Report Tara Bannow Hospitals have been financially propping up medical schools, but now it’s squeezing their bottom lines
Special Report Lev Facher NIH’s identity crisis: The pandemic and the search for a new leader leave the agency at a crossroads
Special Report Rachel Cohrs Why formally ending the pandemic is going to be a huge headache for the entire health care system
Special Report Usha Lee McFarling The nation hasn’t made much progress on health equity. These leaders forged ahead anyway
Special Report Casey Ross How a decades-old database became a hugely profitable dossier on the health of 270 million Americans
Special Report Isabella Cueto Jolting the brain’s circuits with electricity is moving from radical to almost mainstream therapy. Some crucial hurdles remain
Special Report Damian Garde It’s the cardiovascular version of Alzheimer’s — and, for a biotech with a promising drug, it could be a windfall
Special Report Adam Feuerstein and Damian Garde Biogen’s reckoning: How the Aduhelm debacle pushed a troubled company and its fractured leadership to the brink
Special Report Olivia Goldhill — STAT and Rosa Furneaux and Madlen Davies — TBIJ ‘Naively ambitious’: How COVAX failed on its promise to vaccinate the world